If MTHFR and COMT associations can be confirmed with larger studies, folate administration, which bypasses the deficiency of folic acid conversion to folate, could be a potential next step for clinical research to determine if folate supplementation may reduce AIS progression. This evidence concerns the gene MTHFR and androgen insensitivity syndrome.